Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000033551Phase 4Not yet recruiting
Phase 4, randomised trial of lidocaine (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Propofol CP50. Planned start Jun 2020; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000033551.